Search

everythinglearnresearchcommunity

for

Search:↓

Cutaneous Lymphadenoma is a unique skin tumor with specific protein markers and common gene mutations that may cause continuous cell growth.

Lacking cyclin D3 reduces skin cancer growth without affecting normal skin cell growth.

Giant solitary trichoepithelioma is a rare, usually non-cancerous hair follicle tumor that can sometimes turn into skin cancer.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Pygo2 is important for early growth and progression of intestinal tumors, and could be a target for treating cancers with certain mutations.

Blocking mTORC1 may help prevent skin cancer by stopping the growth of certain skin stem cells.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.

Increased ODC expression makes normally tumor-resistant mice more prone to tumor development.

High levels of ornithine decarboxylase can cause tumors in mouse skin.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Krt15+ cells in the mouse intestine resist radiation and can start tumors.

Disrupting the Flcn gene in mice causes early kidney cysts and tumors, which can be treated with rapamycin.

Ozone therapy might improve cancer treatment and reduce its side effects.

Mushroom beta-glucans from Ganoderma lucidum can reduce tumor size and metastasis in cancer.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

Hair shaft miR-221 levels can help detect malignant melanoma.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

The woman's rare combination of diseases suggests an unknown factor may predispose individuals to multiple endocrine diseases.

Vitamin D receptor helps control hair growth and could be used to treat certain skin tumors.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Dutasteride may help shrink prostate cancer tumors.

Hair structure worsens as tumors grow in mice.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Using deep learning to predict gene expression from images could help assess colorectal cancer metastasis.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Dutasteride may help treat prostate cancer by causing cancer cells to shrink and die.